| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |